Business
Bud Genius in Stock Buyback Talks
Bud Genius in Stock Buyback Talks.
About this update from Rightsmile Inc
[{"type":"text","content":"\n \n The Board of Directors of Rightsmile Inc., which is soon to be called \n Bud Genius Inc. (Symbol: RIGH), yesterday declared that it is in talks \n regarding a buyback of its common stock.\n \n \n The decision was influenced by company expansion by its new subsidiary, \n Genius Biotech Corporation, which may be listed on the OTC:BB complete \n with a registration.\n \n \n Company CEO, Angel Stanz, provided the following quote: “The number of \n outstanding shares needs to be reduced. All stock buybacks will be \n followed by a corresponding reduction in the number of authorized shares \n as well. We felt it would be cheaper to do this now, before our new \n subsidiary has grown. We have disclosed that we are considering an \n OTC:BB listing for the company, so this is an opportune time for us to \n concentrate shareholder value. By now I have my eye on a few pieces of \n stock that I would like to reclaim. Any buybacks may vary in size, and \n we can’t negotiate everything at once, but that’s okay because it can \n really pay off in the long run. By doing this, we are putting our money \n where our mouth is, because we are in this for the long-term growth.”\n \n \n About Bud Genius\n \n \n An early leader in an industry that many are speculating will grow, Bud \n Genius is one of the first established analytical cannabis laboratories \n in the United States. Bud Genius was launched to bring vendors together \n with doctors, patients, and dispensaries that require certified products \n held to demanding standards. Bud Genius has a vision to expand across \n the US and abroad serving as the beacon of quality for medical cannabis \n and adult-use marijuana through the formation of regional laboratories. \n Certification, data collection, and online reports are the measure by \n which the company gains.\n \n \n For more information please visit: http://www.BudGenius.com\n \n \n The foregoing press announcement contains forward-looking statements \n that can be identified by such terminology such as \"believes,\" \n \"expects,\" \"potential,\" \"plans,\" \"suggests,\" \"may,\" \"should,\" \"could,\" \n \"intends,\" or similar expressions. Such forward-looking statements \n involve known and unknown risks, uncertainties and other factors that \n may cause the actual results to be materially different from ...